Polypeptide hydrogels and uses related thereto

US9840693B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9840693-B2
Application numberUS-201715411125-A
CountryUS
Kind codeB2
Filing dateJan 20, 2017
Priority dateJan 23, 2014
Publication dateDec 12, 2017
Grant dateDec 12, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This disclosure relates to self-assembling peptides that form hydrogels comprising peptide sequences for the activation of signaling pathways. In certain embodiments, the disclosure relates to compositions comprising a recombinant polypeptide comprising a cell signaling sequence, e.g., JAG-1 sequence, fused to a hydrogel polypeptide sequence. In certain embodiments, the disclosure relates to methods of cell culture on three dimensional scaffolds/hydrogels composed of self-assembling peptides disclosed herein.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of growing cells comprising placing an isolated cell on or in a hydrogel under conditions such that the cell replicates, wherein hydrogel comprises a recombinant polypeptide in combination with a hydrogel polypeptide, wherein the recombinant polypeptide comprises a cell signaling sequence, wherein the cells signal sequence comprises SEQ ID NO: 1, fused to a hydrogel polypeptide sequence, wherein the hydrogel polypeptide and the recombinant polypeptide are in a ratio of between 1:5 to 1:15 by weight, and wherein the hydrogel polypeptide and the recombinant peptide are 1.5% to 2.5% by weight to volume of the hydrogel. 2. The method of claim 1 , wherein the isolated cell is a stem cell, progenitor cell, cardiac stem cell, cardiac progenitor cell, bone marrow derived cell, or mesenchymal stem cell. 3. The method of claim 2 , wherein the cardiac progenitor cell is isolated by the process of selecting cells for stem cell surface markers, progenitor cell surface markers, or cardiac cell surface markers. 4. The method of claim 1 , wherein the hydrogel comprises a saccharide at a concentration of between 100 nm to 500 mM. 5. The method of claim 1 , wherein the hydrogel comprises a buffer creating a pH of between 7.0 to 7.7. 6. The method of claim 1 , wherein the hydrogel further comprising a cardiac progenitor cell.

Assignees

Inventors

Classifications

  • Molecules with a "CD"-designation not provided for elsewhere · CPC title

  • Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof · CPC title

  • Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes (vascular smooth muscle A61K35/44) · CPC title

  • Proteins · CPC title

  • General culture methods using substrates (for specific animal cell type C12N5/06) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9840693B2 cover?
This disclosure relates to self-assembling peptides that form hydrogels comprising peptide sequences for the activation of signaling pathways. In certain embodiments, the disclosure relates to compositions comprising a recombinant polypeptide comprising a cell signaling sequence, e.g., JAG-1 sequence, fused to a hydrogel polypeptide sequence. In certain embodiments, the disclosure relates to me…
Who is the assignee on this patent?
Univ Emory, Georgia Tech Res Inst
What technology area does this patent fall under?
Primary CPC classification C12N5/0657. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).